GROUP ONE TRADING LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is and the CUSIP is 86627T958. A total of 4 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$850,980
+1317.6%
109,100
+652.4%
0.00%
Q1 2024$60,030
+5.0%
14,500
-33.8%
0.00%
Q4 2023$57,159
-42.3%
21,900
-58.7%
0.00%
Q3 2023$99,110
-60.9%
53,000
-47.5%
0.00%
-100.0%
Q2 2023$253,259
-26.0%
100,900
-48.4%
0.00%0.0%
Q1 2023$342,125
-55.8%
195,500
+7.2%
0.00%
-50.0%
Q4 2022$774,775
+25725.8%
182,300
+16472.7%
0.00%
Q4 2021$3,000
-66.7%
1,100
-38.9%
0.00%
Q3 2021$9,000
+50.0%
1,800
+125.0%
0.00%
Q2 2021$6,0008000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING LLC 195,500$342,1250.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 37,500$650.00%
JANE STREET GROUP, LLC 25,300$44,2750.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders